The Department of Health and Human Services (HHS) finalized the 2026 Marketplace Final Rule that enacts protections that were previously proposed in October. Read the rules that will possibly affect how agents, consumers, and carriers interact with the marketplace.

Federal employees anticipating new Medicare Advantage plan coverage may have experienced interference with their enrollment due to auto reenrollment into their existing Federal Employee Program plan.

CMS released their MA & PDP Proposed Rule for CY2026 on November 26, 2024. Learn the biggest potential updates we believe will impact you and your clients.

Find out which carrier's have made some of their Medicare Advantage plans non-commissionable and how you can overcome this change.

What are the 2025 Medicare Part A and Part B premiums, deductibles, and coinsurance amounts? Here's what Original Medicare could cost beneficiaries this year.

On October 17, 2024, CMS announced new security measures for marketplace submissions through a Classic Direct Enrollment or Enhanced Direct Enrollment platform to enhance consumer protections!

One million beneficiaries are receiving a new Medicare Beneficiary Identifier and Medicare card following a data breach involving Wisconsin Physicians Service Insurance Corporation.

Recently, the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) released their Notice of Benefit and Payment Parameters (NBPP) for 2026 Proposed Rule.

Cigna intends to sell their Medicare Advantage, Part D, supplemental benefits, and CareAllies businesses to Health Care Service Corporation (HCSC).

The 2025 Cost of Living Adjustment (COLA) for Social Security benefits has just been announced. See how this adjustment can offer relief to your clients.

On Friday, September 27, CMS released their annual Medicare Advantage and Part D outlook for 2025 and the projections reflect stability and improvements for beneficiaries.

On August 15, 2024, CMS announced the 2026 maximum fair prices for the first 10 drugs in the Medicare Drug Price Negotiation Program. Price reductions for the Medicare-negotiated drugs span from 38 percent to 79 percent!

With the majority of premium increases falling on the stand-alone Part D plans in mind, CMS is establishing a new Part D premium stabilization program to prevent market disruption and help maintain consistent and lower-cost PDP options for beneficiaries.

Get ready to inform your clients about the Inflation Reduction Act’s new Medicare Prescription Payment Plan program!